Insulin resistance due to mutations of the insulin receptor gene: an overview. 1992

D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
March 1991, The Journal of biological chemistry,
D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
January 2007, Molecular and cellular endocrinology,
D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
January 2015, Anales de pediatria (Barcelona, Spain : 2003),
D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
February 1991, Nihon rinsho. Japanese journal of clinical medicine,
D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
July 2002, Nihon rinsho. Japanese journal of clinical medicine,
D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
July 2012, Nihon rinsho. Japanese journal of clinical medicine,
D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
January 2011, Endocrine journal,
D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
December 2017, Pediatric diabetes,
D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
May 2015, Journal of medical genetics,
D Accili, and A Cama, and F Barbetti, and H Kadowaki, and T Kadowaki, and S I Taylor
January 1995, Annales de biologie clinique,
Copied contents to your clipboard!